Cocrystal Pharma raises $1.03M in private placement with four insider investors at $1.39/unit

Cocrystal Pharma, Inc.

Sold 739,426 units (1 share + 2 warrants) at $1.39/unit for $1.03M to four accredited insider purchasers.
Warrants exercisable at $1.24/share for 27 months; potential additional $1.83M if fully exercised.
Insiders include Directors Phillip Frost, Fred Hassan, Richard Pfenniger, and co-CEO/CFO James Martin.
Proceeds to support clinical antiviral development programs and general working capital.
Offering exempt under Section 4(a)(2) and Regulation D; no registration rights granted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.